
Rimonci Capital
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
A dedicated to China-Israel cross border investment.
Investor Profile
Rimonci Capital has backed more than 6 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in Israel, France, United States.
- Strong thematic focus on Health Care, Medical Device, Laser.
Stage Focus
- Series A (67%)
- Series B (17%)
- Seed (17%)
Country Focus
- Israel (67%)
- France (17%)
- United States (17%)
Industry Focus
- Health Care
- Medical Device
- Laser
- Eyewear
- Artificial Intelligence (Ai)
- Assistive Technology
- Hospital
- Medical
- Mhealth
- Wellness
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.